Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D08RQW
|
||||
Former ID |
DIB020359
|
||||
Drug Name |
MK-5046
|
||||
Synonyms |
MK 5046; MK5046
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [541356] | ||
Structure |
Download2D MOL |
||||
Formula |
C20H18F6N4O
|
||||
InChI |
InChI=1S/C20H18F6N4O/c21-19(22,23)17(6-7-17)10-14-12-27-16(29-14)11-18(31,20(24,25)26)13-2-4-15(5-3-13)30-9-1-8-28-30/h1-5,8-9,12,31H,6-7,10-11H2,(H,27,29)/t18-/m0/s1
|
||||
InChIKey |
UJINBEQCDMOAHM-SFHVURJKSA-N
|
||||
PubChem Compound ID | |||||
PubChem Substance ID | |||||
Target and Pathway | |||||
Target(s) | Bombesin receptor | Target Info | Agonist | [531243] | |
Gastrin-releasing peptide receptor | Target Info | Agonist | [532441] | ||
References | |||||
Ref 531243 | Antiobesity effect of MK-5046, a novel bombesin receptor subtype-3 agonist. J Pharmacol Exp Ther. 2011 Feb;336(2):356-64. | ||||
Ref 532441 | Comparative pharmacology of bombesin receptor subtype-3, nonpeptide agonist MK-5046, a universal peptide agonist, and peptide antagonist Bantag-1 for human bombesin receptors. J Pharmacol Exp Ther. 2013 Oct;347(1):100-16. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.